Paying for innovation: Reimbursement incentives for antibiotics-Reference-Cited by-同舟云学术

Paying for innovation: Reimbursement incentives for antibiotics

Published:2015-02-25 Issue:276 Volume:7 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Hwang Thomas J.¹²,Carpenter Daniel¹³,Kesselheim Aaron S.⁴

Affiliation:

1. Faculty of Arts and Sciences, Harvard University, Cambridge, MA 02138, USA.

2. The Blackstone Group, London W1J 5AL, UK.

3. Radcliffe Institute for Advanced Study, Harvard University, Cambridge, MA 02138, USA.

4. Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02120, USA.

Abstract

Reimbursement incentives could promote antibiotic research and development—in particular, for new drugs to treat complex infections commonly found in hospitals.

Funder

Greenwall Foundation Faculty Scholarship

Interfaculty Initiative in Health Policy

Center for American Political Studies

Dunwalke Fund

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference10 articles.

1. Target small firms for antibiotic innovation

2. President’s Council of Advisors on Science and Technology Report to the President on Combating Antibiotic Resistance. Executive Office of the President (2014).

3. The Roles Of Academia, Rare Diseases, And Repurposing In The Development Of The Most Transformative Drugs

4. The Calculus of Cures

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Key factors in antibiotic resistance;Journal of Global Infectious Diseases;2019

2. Nanoparticles as New Emerging Antibacterials: Potentials and Limitations;Antibacterial Drug Discovery to Combat MDR;2019

3. Factors pivotal for designing of nanoantimicrobials: an exposition;Critical Reviews in Microbiology;2017-04-19

4. Innovative payer engagement strategies: will the convergence lead to better value creation in personalized medicine?;EPMA Journal;2017-02-13

5. Promoting Antibacterial Drug Development: Select Policies and Challenges;Applied Health Economics and Health Policy;2016-09-06